Loading...
NPI 1982940862 · Zachary, LA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Medcomp Sciences LLC is a clinical medical laboratory provider located in Zachary, Louisiana. This profile covers 3 Medicare and 139 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Medcomp Sciences LLC |
| Address | 20203 Machost Rd |
| City | Zachary |
| State | LA |
| ZIP | 70791 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | December 20, 2012 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $12.9M |
| Medicare | $45.7K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 130 | $240 | $30K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 70 | $200 | $13.8K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 30 | $60 | $1.8K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 3 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
139 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 38,970 | $110 | $4.3M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 36,580 | $40 | $1.4M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 15,660 | $80 | $1.3M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 28,540 | $30 | $941.7K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 16,430 | $30 | $492.8K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 5,420 | $60 | $314.2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3,190 | $60 | $188.4K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 2,760 | $60 | $157K |
| 80372 | The lab analyst measures the amount of or detects the presence of tapentadol, a centrally acting opioid pain medication, in the patient specimen. | 15,650 | $10 | $156.5K |
| 80368 | The lab analyst measures the amount of or detects the presence of non–benzodiazepine sedative hypnotics in a patient specimen. | 14,850 | $10 | $148.5K |
Showing 1–10 of 139
How this provider's Medicaid billing volume and revenue compare to other Louisiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Louisiana median
139 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 34 | 70 | 620 | $230 | $913.4K |
| 87541 | The lab analyst performs a test for the bacteria Legionella pneumophila using amplified nucleic acid probe technique. L. pneumophila can inhabit facility water and air conditioning systems and may… | 3 | 10 | 350 | $20 | $668.7K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2 | 30 | 1,340 | $60 | $499.3K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 14 | 90 | 650 | $40 | $404.2K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 5 | 20 | 690 | $20 | $359.2K |
| 87532 | The lab analyst performs a test for Herpes virus 6 using amplified nucleic acid probe technique. Herpes virus 6, also called human herpes virus 6 or HHV6, causes a common childhood rash, roseola, and… | 2 | 10 | 790 | $20 | $289.9K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 5 | 30 | 390 | $20 | $285.9K |
| 87496 | The lab analyst performs a test for cytomegalovirus, or CMV, using amplified nucleic acid probe technique. CMV may cause severe illness in newborns and immunocompromised patients. | 2 | 10 | 410 | $20 | $259.5K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 15 | 50 | 530 | $20 | $237.6K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 7 | 170 | 1,360 | $30 | $190K |
Showing 1–10 of 139
Other providers in the same ZIP code as Medcomp Sciences LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Hospital Service District 1 Of East Baton Rouge Parish | LA | General Acute Care Hospital | $0 | $10.1M |
| Bridge Builders Consultants, LLC | LA | In Home Supportive Care Agency | $0 | $8.8M |
| Southeast Community Health Systems | LA | Federally Qualified Health Center (FQHC) | $0 | $5.4M |
| Hospital Service District 1 Of East Baton Rouge Parish | LA | General Acute Care Hospital | $0 | $4.9M |
| Baron Williamson | LA | Ophthalmology Physician | $392K | $254.8K |
| Elizabeth Granger | LA | Optometrist | $15K | $619.6K |
| Babu Jasti | LA | Interventional Cardiology Physician | $535.3K | $0 |
| Michael Oswald | LA | Ophthalmology Physician | $240.6K | $0 |
| Jason Allemond | LA | Optometrist | $81.5K | $146.9K |
| Charles Thompson | LA | Interventional Cardiology Physician | $208.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.